David Cavalla
Fondateur chez Exvastat Ltd.
Postes actifs de David Cavalla
Sociétés | Poste | Début | Fin |
---|---|---|---|
Exvastat Ltd.
Exvastat Ltd. Pharmaceuticals: MajorHealth Technology Exvastat Ltd. operates as pharmaceutical company. The firm develops treatment for acute respiratory distress syndrome (ARDS) based on a repurposed drug which is marketed worldwide for other indications. The company was founded by David Cavalla , Charlotte Summers and Andrew McElroy in 2016 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | 01/01/2016 | - |
Directeur Général | - | - | |
Fondateur | 01/01/2016 | - | |
Numedicus Ltd.
Numedicus Ltd. BiotechnologyHealth Technology Numedicus Ltd. is a world-class drug repurposing British company founded in 2008. The private company is based in Cambridge, UK. Numedicus has identified several clinical-stage drug repurposing projects supported by method-of-use patents. The company uses therapeutic switching to identify secondary uses for existing drugs in practically all areas. David Cavalla, the founder, has 35 years of experience in various senior scientific and commercial roles within the pharmaceutical industry. He is one of the first advocates of drug repurposing and has used this strategy to create three first-in-class developmental products to have successfully passed human proof of concept clinical stages. The company's latest news includes the start of a phase II trial in severe COVID-19 patients. | Directeur/Membre du Conseil | 08/12/2008 | - |
Historique de carrière de David Cavalla
Anciens postes connus de David Cavalla
Sociétés | Poste | Début | Fin |
---|---|---|---|
National Institute of Mental Health | Corporate Officer/Principal | - | - |
GSK Products, Inc.
GSK Products, Inc. Wholesale DistributorsDistribution Services Part of Princeton American Corp., GSK Products, Inc. is a beauty and barber supply concern. The company is based in Phoenix, AZ. | Corporate Officer/Principal | - | - |
Formation de David Cavalla
University of Cambridge | Doctorate Degree |
Statistiques
Internationale
Royaume-Uni | 4 |
Etats-Unis | 3 |
Opérationnelle
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 2 |
Distribution Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 4 |
---|---|
GSK Products, Inc.
GSK Products, Inc. Wholesale DistributorsDistribution Services Part of Princeton American Corp., GSK Products, Inc. is a beauty and barber supply concern. The company is based in Phoenix, AZ. | Distribution Services |
National Institute of Mental Health | Government |
Exvastat Ltd.
Exvastat Ltd. Pharmaceuticals: MajorHealth Technology Exvastat Ltd. operates as pharmaceutical company. The firm develops treatment for acute respiratory distress syndrome (ARDS) based on a repurposed drug which is marketed worldwide for other indications. The company was founded by David Cavalla , Charlotte Summers and Andrew McElroy in 2016 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Numedicus Ltd.
Numedicus Ltd. BiotechnologyHealth Technology Numedicus Ltd. is a world-class drug repurposing British company founded in 2008. The private company is based in Cambridge, UK. Numedicus has identified several clinical-stage drug repurposing projects supported by method-of-use patents. The company uses therapeutic switching to identify secondary uses for existing drugs in practically all areas. David Cavalla, the founder, has 35 years of experience in various senior scientific and commercial roles within the pharmaceutical industry. He is one of the first advocates of drug repurposing and has used this strategy to create three first-in-class developmental products to have successfully passed human proof of concept clinical stages. The company's latest news includes the start of a phase II trial in severe COVID-19 patients. | Health Technology |
- Bourse
- Insiders
- David Cavalla
- Expérience